Revolutionizing Cancer Care Through Innovative Technology Solutions and Patient-Centered Approach.
Pioneering Cancer Care: How Flatiron Health is Making a Difference
Flatiron Health is a healthcare technology company that is revolutionizing cancer research and care. The company was founded in 2012 by Nat Turner and Zach Weinberg with a mission to improve cancer care through innovative technology solutions.
The quality of people at Flatiron Health is something that stands the company in good stead. People at Flatiron are a good mix of software engineers, quantitative scientists, oncologists, product managers, designers, and visionaries – working together to take on cancer. With a prevalent culture that focuses on values, they work hard to support an environment inclusive of learning and empathy. The company hosts Wellness days on a monthly basis with a special focus on employee wellness. Moreover, the company on a bi-weekly basis hosts a meditation session in the office. On top of these a competitive salary, robust learning and development curriculum, flexible work hours, generous parental leaves and endless snacks are only a few among the many perks the employees at Flatiron enjoy.
But what sets Flatiron Health apart from other companies in the healthcare space is their commitment to interacting with patients. While there are many companies that are working towards curing cancer and helping out in research, there are few companies that actually look to connect with the patients. Flatiron takes connecting with patients to be an important part of what they do. Every few months, Flatiron hosts someone who is living with cancer at their office so that the employees can ask their questions. The visitors have inspired projects which make a tremendous impact on the battle against the disease. The company also holds their annual event called “All-Hands Meeting” which brings the team behind Flatiron together every year to make decisions cohesively.
advancing the treatment of cancer
Flatiron Health’s software platform seeks to connect cancer centers across the United States so that what is learned is shared in an efficient way. Flatiron works with over 285 oncology practices and top 15 therapeutic oncology companies to help those in research derive the right insights from the organized data sets. The OncoCloud Suite from Flatiron has been enabling companies across the U.S. to make informed choices so that the patient care of the future benefits from the data available.
In this country which thrives on value-based care, over 2,500 clinicians at over 800 geographically diverse sites have selected Flatiron as their technology partner. And with over 700 employees on its payroll, 2.2 million active patient records available on its solutions for research, and seven major academic research partners, the company is taking giant strides towards accelerating the cancer research and treatment.
Flatiron Health’s impact on the healthcare industry has not gone unnoticed. In 2018, the company was acquired by Roche, a global pharmaceutical and diagnostic company, for $2.1 billion. This acquisition has allowed Flatiron to expand its reach and continue to innovate in the field of oncology.
finally, Flatiron Health is a company that is making a real difference in the world of healthcare. With their commitment to innovation, patient-centered care, and a supportive workplace culture, they are transforming the way cancer research and care is conducted. The company’s unique approach and success have made them a model for other companies to follow. Flatiron Health is truly a leader in the fight against cancer.
MEET THE CEO
Carolyn Starrett is the CEO of Flatiron Health. Starrett joined the company in 2014 as the Head of Oncology Strategy and was later promoted to Chief Operating Officer. She has extensive experience in healthcare technology and previously worked at Athenahealth, a healthcare technology company, where she held several leadership roles.
As CEO of Flatiron Health, Starrett is responsible for overseeing the company’s strategic direction and operations, as well as ensuring that the company continues to innovate and develop new products and services that improve cancer care.
